John Ruxer, DO
Pain Medicine · Paducah, KYNPI 1205078987
Payments from drug & device makers
Across 523 payments — averaging $62.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$24K
- Medtronic$2K
- Abbott$1K
- Collegium Pharmaceutical, Inc.$1K
- Amgen$926
- Si-bone, Inc.$688
- plus $2K from 28 others
What the payments were for
- Consulting fees$1,6005%
- Speaking & faculty fees$19,58860%
- Travel & lodging$3371%
- Food & beverage$11,28234%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 115 | $24,354 |
| Medtronic(2 entities) | 70 | $2,449 |
| Abbott | 39 | $1,115 |
| Collegium Pharmaceutical, Inc. | 88 | $1,057 |
| Amgen(2 entities) | 63 | $926 |
| Si-bone, Inc. | 16 | $688 |
| Nevro Corp. | 11 | $302 |
| Pfizer | 27 | $245 |
| Globus Medical | 2 | $231 |
| AbbVie(2 entities) | 10 | $202 |
| Curonix LLC | 2 | $156 |
| Biohaven Pharmaceutical Holding Company Ltd. | 17 | $154 |
| Scilex Pharmaceuticals Inc. | 10 | $141 |
| Novartis | 6 | $87 |
| Ferring Pharmaceuticals Inc. | 5 | $78 |
| Lilly USA, LLC | 6 | $75 |
| Zyla Life Sciences, Inc. | 5 | $65 |
| Averitas Pharma Inc. | 2 | $60 |
| Biodelivery Sciences International, Inc. | 4 | $58 |
| Spinal Simplicity, LLC | 3 | $50 |
| Daiichi Sankyo Inc. | 4 | $49 |
| Hikma Pharmaceuticals USA | 3 | $47 |
| Ultragenyx Pharmaceutical Inc. | 2 | $38 |
| Assertio Therapeutics, Inc. | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Stryker | 1 | $23 |
| Vertex | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $16 |
| Akcea Therapeutics, Inc. | 1 | $15 |
| MDD US Operations, LLC | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,850 in reported general payments places this provider in the 90th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 158 | $120,536 |
| Xtampza ErOxycodone Myristate | 104 | $62,167 |
| Buprenorphine | 165 | $52,804 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,441 | $47,180 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,512 | $27,372 |
| OxycontinOxycodone Hcl | 16 | $10,894 |
| Oxycodone Hcl | 384 | $7,468 |
| Morphine Sulfate ErMorphine Sulfate | 246 | $4,804 |
| Pregabalin | 142 | $2,941 |
| Gabapentin | 241 | $2,507 |
| Fentanyl | 22 | $2,366 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 15 | $1,857 |
| Naloxone Hcl | 27 | $1,471 |
| Methadone Hcl | 106 | $1,399 |
| Morphine Sulfate | 73 | $1,271 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $1,057 | $182,703262 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $47 | $54,075238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 90 pain medicine providers in Kentucky.
Other pain medicine in Paducah
- Megan FordPaducah$3K
- Steven RupertPaducah$2K
- Anjum BuxDanville$596K
- Christopher MallardLexington$84K
- Timothy BeachamLouisville$53K
- Michael HarnedLexington$45K
- Vinod MuniswamyGeorgetown$39K
- Mazhar RasulLexington$30K
- Tejas ShahAshland$23K
- Lance HoffmanFlorence$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.